Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about GILD

Recent news which mentions GILD

< Previous 1 2
...
6 7 8 9 10 11 12 13 14
...
17 18 Next >
WHO Backs Pfizer's Oral COVID Antiviral Therapy For High-Risk Patients
Tickers GILD PFE
Tags Health Care News Top Stories
From Benzinga
Pfizer: What Comes After the Covid-19 Fire?
Tickers BMY BNTX CVS GILD
Tags CVS BMY IBB
From InvestorPlace
FDA Puts Blood Cancer Nods Under Scrutiny On Substantial Toxicity Profile Of PI3K Drugs
Tickers BAYRY BAYZF GILD NVS
Tags GILD NVS General
From Benzinga
NRx Pharmaceuticals Again Requests For FDA Breakthrough Therapy Status For COVID-19 Therapy
Tickers GILD NRXP
Tags Biotech News Health Care
From Benzinga
If You Invested $1000 In Gilead Sciences 20 Years Ago, Here's How Much You Would Have Today
Tickers GILD
Tags News Earnings Market News
From Benzinga
2 Unstoppable Green Flags for AbbVie
Tickers ABBV AZN BMY GILD
Tags AZN ROG NVS
From Motley Fool
Why Is Sierra Oncology (SRRA) Stock Up Today?
Tickers ATRS GILD GSK HALO
Tags GSK SRRA GILD
From InvestorPlace
Why Sierra Oncology Stock Is Soaring Today
Tickers GILD GSK SRRA
Tags Recent Press Releases GILD Market News
From Motley Fool
The Daily Biotech Pulse: Aeglea Stock Jumps On Inherited Metabolic Disease Data, Partial Hold Lifted On Gilead's 2 Blood Trials, Early Data From Novartis' KRAS Inhibitor And More
Tickers AGLE ALPN ATNM BDSX
Tags News ALPN GILD
From Benzinga
FDA Lifts Partial Clinical Hold On Gilead's MDS, AML Magrolimab Studies
Tickers GILD
Tags Briefs acute myeloid leukemia Clinical Holds
From Benzinga
Gilead says FDA lifts partial clinical hold on MDS and AML magrolimab studies
Tickers GILD
Tags GILD
From MarketWatch
10 Health Care Stocks Whale Activity In Today's Session
Tickers ANTM BCRX FIGS GILD
Tags IDXX GILD MRNA
From Benzinga
Here's Why a Drop in Moderna's Revenue Wouldn't Be Catastrophic
Tickers ABBV BMY GILD MRK
Tags GILD BMY MRNA
From Motley Fool
Layoffs at Bluebird Bio Highlight the Current Struggles of Biotech Picks
Tickers BIIB BLUE GILD IBB
Tags BLUE NASDAQ:BLUE,NASDAQ:IBB,NYSEARCA:XBI,NASDAQ:MRNA,,NYSE:NVS,NASDAQ:GILD,NYSE:MRK,NASDAQ:BIIB,NYSE:PFE XBI
From InvestorPlace
Where Gilead Sciences Stands With Analysts
Tickers GILD
Tags GILD Analyst Ratings Benzinga
From Benzinga
Here's How Much You Would Have Made Owning Gilead Sciences Stock In The Last 20 Years
Tickers GILD
Tags GILD Dividends Benzinga
From Benzinga
10 Biggest Price Target Changes For Monday
Tickers BAX CALA CARR GILD
Tags CARR CALA Analyst Ratings
From Benzinga
Gilead's Yescarta Scores FDA Approval As First CAR T-Cell Therapy For Earlier Lymphoma
Tickers GILD
Tags GILD General FDA
From Benzinga
2 Drugmakers Set for Explosive Revenue This Decade
Tickers ABBV AZN BMY GILD
Tags JNJ Recent Press Releases ABBV
From Motley Fool
The Daily Biotech Pulse: Amylyx Announces Negative Adcom Vote, Clovis Jumps On Ovarian Cancer Data, Masimo Warns Of Q1 Shortfall
Tickers ADMP AFIB AFMD AMLX
Tags CRXT PDSB Earnings
From Benzinga
5 Charts That Show Why Bristol-Myers Squibb Is a No-Brainer Buy
Tickers ABBV BMY BNTX GILD
Tags PFE Market News OPHLY
From Motley Fool
Investors Seek Second Act with Moderna Stock
Tickers GILD MRNA
Tags Market News GILD MRNA
From InvestorPlace
FDA Says Current Dose Of GSK-Vir's COVID-19 Therapy Unlikely To Work Against Omicron Subvariant
Tickers GILD GSK LLY MRK
Tags News Biotech Health Care
From Benzinga
2 High-Yielding Stocks Trading Near Multiyear Lows
Tickers GILD UL
Tags UL Recent Press Releases GILD
From Motley Fool
10 Biggest Price Target Changes For Monday
Tickers COIN ETON GILD GRPH
Tags NKE Price Target Changes GILD
From Benzinga
What Cramer Thinks About Hims & Hers Health, Gilead Sciences And More
Tickers DKNG EPD GILD HIMS
Tags TWO Short Sellers News
From Benzinga
Todos Medical Acquires Lucrative NLC Assets For Pennies On The Dollar
Tickers GILD MRK PFE TOM
Tags Partner Content Benzinga Todos Medical
From Benzinga
Here's How Much You Would Have Made Owning Gilead Sciences Stock In The Last 20 Years
Tickers GILD
Tags Earnings BZI/POD Market News
From Benzinga
Gilead Sciences' Trodelvy Study In Breast Cancer Meets Primary Endpoint
Tickers GILD
Tags Benzinga Briefs Phase 3 Trial
From Benzinga
The Week Ahead In Biotech (March 6-12): Quiet Week On Tap With Earnings Season Reaching It Final Leg
Tickers ACHV ACOR AMPH AMYT
Tags AQST AMYT NVCN
From Benzinga
< Previous 1 2
...
6 7 8 9 10 11 12 13 14
...
17 18 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.